SCHEDULE 13G Filed 2026-06-03 Event — SEC 0001831942-26-000028 →

Commodore Capital LP → EyePoint, Inc. EYPT

Stake: — Shares: — Class: Common Stock, par value $0.001

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 21/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (8.1 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 8.07

21,260,757 shares short · +2.3% vs prior

Other 13D/G Filings on EyePoint, Inc.

Filed	Form	Filer	Stake	Shares
2026-09-08	SCHEDULE 13G	Janus Henderson Group Ltd.	—	—	view →
2019-02-13	SC	EW Healthcare Partners, L.P.	—	—	view →
2018-07-05	SC	EW Healthcare Partners, L.P.	—	—	view →

Other Filings by Commodore Capital LP

Filed	Form	Issuer	Stake	Shares
2026-10-07	SCHEDULE 13G	Sagimet Biosciences Inc.	—	—	view →
2026-10-01	SCHEDULE 13G	Surrozen, Inc./DE	—	—	view →
2026-09-02	SCHEDULE 13G	JATT III Acquisition Corp	—	—	view →
2026-08-17	SCHEDULE 13G	InflaRx N.V.	—	—	view →
2026-07-20	SCHEDULE 13G	Research Alliance Corp IV	—	—	view →
2026-06-18	SCHEDULE 13G	Avalo Therapeutics, Inc. AVTX	—	—	view →
2026-06-02	SCHEDULE 13G	Editas Medicine, Inc. EDIT	—	—	view →
2026-05-28	SCHEDULE 13G	Research Alliance Corp III RACC	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →